Gender-related prognostic value and genomic pattern of intra-tumor heterogeneity in colorectal cancer

Carcinogenesis
Jieyun ZhangWeijian Guo

Abstract

Intra-tumor heterogeneity (ITH) is crucial in tumorigenesis and resistance to target therapy. Here, we used mutant-allele tumor heterogeneity (MATH) to measure ITH based on next-generation sequencing data and high MATH was proven as an independent risk prognostic factor in male CRC patients in both a training set of 284 colorectal cancer (CRC) patients with from The Cancer Genome Atlas (TCGA) and a validating set of 187 CRC patients from International Cancer Genome Consortium (ICGC). Further, the genomic pattern according to MATH demonstrated that mutation rates of TP53, IRF5 and KRAS were independently associated with MATH, and the latter two were only significant in male patients. As MATH increased, the fraction of somatic copy number alteration (SCNA) elevated. Moreover, more SCNA events was independently associated with MATH in male than in female. WNT pathway, TGF-β pathway and DNA repair deficiency was enriched in high MATH group and the latter two showed up only in male patients. In summary, we reveal the gender-related prognostic value of MATH and relevant genomic pattern in CRC. Potential mechanisms are provided and it remains to be proven whether they are drivers of subclone formation and ITH. Taking MATH into conside...Continue Reading

References

Jun 22, 2002·Gut·R SalovaaraL A Aaltonen
Jan 2, 2003·Annals of Botany·Olga BlokhinaKurt V Fagerstedt
Mar 8, 2003·International Journal of Gastrointestinal Cancer·Irmgard Schwarte-Waldhoff, Wolff Schmiegel
Mar 29, 2003·Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology·Rajeshwar P Sinha, Donat P Häder
Aug 30, 2003·Oncogene·Peiwen Fei, Wafik S El-Deiry
Jul 27, 2004·Science·Jonathan SebatMichael Wigler
Sep 8, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Pia AlhopuroDiego Arango
Oct 27, 2006·The Journal of Molecular Diagnostics : JMD·Shuji OginoCharles S Fuchs
Nov 26, 2009·Biochimica Et Biophysica Acta·Andriy Marusyk, Kornelia Polyak
Feb 24, 2010·Nature Reviews. Molecular Cell Biology·Simona NegriniThanos D Halazonetis
Mar 15, 2011·Nature·Nicholas NavinMichael Wigler
Apr 4, 2012·The Lancet Oncology·Nicholas C Turner, Jorge S Reis-Filho
Apr 20, 2012·Nature Reviews. Cancer·Andriy MarusykKornelia Polyak
Jul 20, 2012·Nature·UNKNOWN Cancer Genome Atlas Network
Sep 21, 2013·Nature·Rebecca A BurrellCharles Swanton
Mar 19, 2014·Nature Methods·Andrew RothSohrab P Shah
Oct 1, 2014·International Journal of Molecular Sciences·Rola H AliFahd Al-Mulla
Apr 9, 2015·Nature Reviews. Clinical Oncology·Naoko TakebeS Percy Ivy
Jun 18, 2015·International Journal of Molecular Sciences·Moisés Blanco-CalvoManuel Valladares-Ayerbes
Sep 16, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tanya KeenanAditya Bardia
Dec 1, 2015·Nature Medicine·Noemi AndorCarlo C Maley
Feb 11, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Pu YanRoberto Fiocca

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.